Level 9, 365 Little Collins Street, Melbourne, Victoria, 3000
Michael Goldberg (Managing Director and Portfolio Manager of the Collins St Value Fund) provides an overview of the investment thesis supporting the Funds’ investment into the ASX listed Paradigm Biopharmaceuticals.
Chief investment Officer Vasilios Piperoglou discusses some of the more surprising investment plays from the Collins St Global Fund & Collins St Value Fund
Investment Analyst Steven Ermidis explores the effects of the FIFA World Cup and a football hungry clientele on this dominant UK fast food chain.
Access the complete presentation deck with portfolio insights and investment examples
Get instant online access to key fund features, metrics and performance
Get instant online access to complete fund details, investment strategy, and terms
We anticipated the strong uranium market in 2017. Gold in 2019. Gold again in 2023. Find out what we think is next.